pubmed.ncbi.nlm.nih.gov

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels - PubMed

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels

Paola Portillo-Sanchez et al. J Clin Endocrinol Metab. 2015 Jun.

Abstract

Context and objective: Nonalcoholic fatty liver disease (NAFLD) and its more severe form with steatohepatitis (NASH) are common in patients with type 2 diabetes mellitus (T2DM). However, they are usually believed to largely affect those with elevated aminotransferases. The aim of this study was to determine the prevalence of NAFLD by the gold standard, liver magnetic resonance spectroscopy ((1)H-MRS) in patients with T2DM and normal aminotransferases, and to characterize their metabolic profile.

Participants and methods: We recruited 103 patients with T2DM and normal plasma aminotransferases (age, 60 ± 8 y; body mass index [BMI], 33 ± 5 kg/m(2); glycated hemoglobin [A1c], 7.6 ± 1.3%). We measured the following: 1) liver triglyceride content by (1)H-MRS; 2) systemic insulin sensitivity (homeostasis model assessment-insulin resistance); and 3) adipose tissue insulin resistance, both fasting (as the adipose tissue insulin resistance index: fasting plasma free fatty acids [FFA] × insulin) and during an oral glucose tolerance test (as the suppression of FFA).

Results: The prevalence of NAFLD and NASH were much higher than expected (50% and 56% of NAFLD patients, respectively). The prevalence of NAFLD was higher in obese compared with nonobese patients as well as with increasing BMI (P = .001 for trend). Higher plasma A1c was associated with a greater prevalence of NAFLD and worse liver triglyceride accumulation (P = .01). Compared with nonobese patients without NAFLD, patients with NAFLD had severe systemic (liver/muscle) and, particularly, adipose tissue (fasting/postprandial) insulin resistance (all P < .01).

Conclusions: The prevalence of NAFLD is much higher than previously believed in overweight/obese patients with T2DM and normal aminotransferases. Moreover, many are at increased risk of NASH. Physicians should have a lower threshold for screening patients with T2DM for NAFLD/NASH.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.

Relationship between BMI and liver triglyceride content measured by 1H-MRS. A, Correlation between BMI and liver triglyceride content. B, Prevalence of NAFLD according to different BMI groups (n = 31, 34, 29, and 9, respectively).

Figure 2.
Figure 2.

The role of obesity and NAFLD on adipose tissue insulin sensitivity. A, Adipo-IRindex (Adipo-IRindex = fasting plasma FFA × fasting plasma insulin concentration). B, Percentage suppression of plasma FFA concentration after an OGTT. Patients with NAFLD had worse adipose tissue insulin resistance when compared with those without NAFLD (No-NAFLD). Results are expressed as the mean ± SEM. P-value represents P for trend (n = 7, 10, 16, and 49, respectively).

Figure 3.
Figure 3.

Relationship between glycemic control on liver triglyceride content measured by 1H-MRS. A, Correlation between plasma A1c levels and liver triglyceride content. B, Prevalence of NAFLD among patients with a broad spectrum of plasma A1c levels (n = 15, 19, 54, and 15, respectively).

Similar articles

Cited by

References

    1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686–690. - PubMed
    1. Lazo M, Hernaez R, Eberhardt MS, et al. . Prevalence of nonalcoholic fatty liver disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol. 2013;178:38–45. - PMC - PubMed
    1. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol. 2007;102:2716–2717. - PubMed
    1. Williams CD, Stengel J, Asike MI, et al. . Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology. 2011;140:124–131. - PubMed
    1. Szczepaniak LS, Nurenberg P, Leonard D, et al. . Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462–E468. - PubMed

Publication types

MeSH terms

Substances